BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2237132)

  • 1. Current advances in the diagnosis and treatment of AIDS: an introduction.
    Groopman JE
    Rev Infect Dis; 1990; 12(5):908-11. PubMed ID: 2237132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT
    Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma.
    Krown SE
    J Interferon Cytokine Res; 1998 Apr; 18(4):209-14. PubMed ID: 9568721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
    Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
    Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enhanced potential use of recombinant alpha interferon in the treatment of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT
    Oncol Nurs Forum; 1989; 16(6 Suppl):5-7. PubMed ID: 2594553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma.
    Fischl MA
    Am J Med; 1991 Apr; 90(4A):2S-7S. PubMed ID: 2018047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview.
    Clumeck N; Hermans P
    Am J Med; 1988 Aug; 85(2A):165-72. PubMed ID: 2457313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
    Gill PS
    Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
    Aboulafia DM
    Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
    Klatt EC; Nichols L; Noguchi TT
    Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AIDS therapy].
    Hutterer J
    Z Hautkr; 1990 Jul; 65(7):664-70. PubMed ID: 2205064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
    J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results.
    Longo DL; Steis RG; Lane HC; Lotze MT; Rosenberg SA; Preble O; Masur H; Rook AH; Fauci AS; Jacob J
    Ann N Y Acad Sci; 1984; 437():421-30. PubMed ID: 6598311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma.
    Rosales CM; McLaughlin MD; Sata T; Katano H; Veno PA; de Las Casas LE; Miranda RN
    AIDS Patient Care STDS; 2002 Dec; 16(12):573-7. PubMed ID: 12542930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.
    Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT
    Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.